Bactiguard Holding AB (CHIX:BACTBS) LT-Debt-to-Total-Asset: 0.27 (As of Mar. 2026)


CHIX:BACTBS Bactiguard Holding AB CHIX:BACTBS
51 GF Score
Price kr128.60
GF Value kr274.02
! 2 Warning Signs
View Full Analysis

What is Bactiguard Holding AB LT-Debt-to-Total-Asset?

Bactiguard Holding AB CHIX:BACTBS 51 LT-Debt-to-Total-Asset is 0.27 as of Mar. 2026. GuruFocus rates CHIX:BACTBS with a GF Score™ of 51/100 and a GF Value™ of kr274.02. The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bactiguard Holding AB's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.27.

Bactiguard Holding AB's long-term debt to total assets ratio increased from Mar. 2025 (0.27) to Mar. 2026 (0.27). It may suggest that Bactiguard Holding AB is progressively becoming more dependent on debt to grow their business.


Bactiguard Holding AB  (CHIX:BACTBs) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Bactiguard Holding AB LT-Debt-to-Total-Asset Related Terms


Bactiguard Holding AB LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Bactiguard Holding AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bactiguard Holding AB LT-Debt-to-Total-Asset Chart

Bactiguard Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.28 0.06 0.06 0.27

Bactiguard Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.28 0.28 0.27 0.27
CHIX:BACTBS
51GF Score
Bactiguard Holding AB CHIX:BACTBS
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bactiguard Holding AB LT-Debt-to-Total-Asset Calculation

Bactiguard Holding AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=148.845/545.063
=0.27

Bactiguard Holding AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=147.019/537.338
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.27 mean?
Bactiguard Holding AB (CHIX:BACTBS) has a LT-Debt-to-Total-Asset of 0.27 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bactiguard Holding AB and its competitors.
Is Bactiguard Holding AB's LT-Debt-to-Total-Asset too high?
Bactiguard Holding AB's current LT-Debt-to-Total-Asset is 0.27. Overall, Bactiguard Holding AB has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's LT-Debt-to-Total-Asset compare to ABT and SYK?
Bactiguard Holding AB's LT-Debt-to-Total-Asset of 0.27 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current LT-Debt-to-Total-Asset is 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current LT-Debt-to-Total-Asset of 0.27. The stock's GF Value™ is kr274.02, compared to a current price of kr128.60 — trading 53.1% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.27. Bactiguard Holding AB's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current LT-Debt-to-Total-Asset is 0.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?

Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued. The current stock price of kr128.60 is trading 53.1% below its estimated GF Value™ of kr274.02.

Key valuation signals for CHIX:BACTBS:

  • LT-Debt-to-Total-Asset: 0.27
  • GF Value™: kr274.02 vs. price of kr128.60 (53.1% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bactiguard Holding AB Business Description

Other Exchanges BACTI B:Sweden5JE:Germany
Address Vasagatan 11, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
51GF Score

Get the complete analysis for CHIX:BACTBS

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr128.60
Price
kr274.02
GF Value